Technology
Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results
Press Release Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results Topline results from the NCX 470 (bimatoprost grenod) Phase 3 Denali clinical trial expected in Q3 2025Cash of €19.7 million on September 30, 2024, including
By: manilatimes
- Oct 17 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS